Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/29924| Title: | MSI+ stage II/III colon cancer patients benefit from capecitabine adjuvant monotherapy | Authors: | Dimovski, Aleksandar Matevska, Nadica Eftimov, Aleksandar Kapedanovska Nestorovska, Aleksandra Angelovska Petrushevska, Natalija Angelovska, Biljana Jashar, Djengis Mitreski, Nenad Josifovski, Toni |
Issue Date: | 2012 | Publisher: | Oxford University Press on behalf of the European Society for Medical Oncology | Journal: | Annals of Oncology | Conference: | ESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 27-30 June 2012 | URI: | http://hdl.handle.net/20.500.12188/29924 |
| Appears in Collections: | Faculty of Medicine: Conference papers Faculty of Medicine: Conference papers |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2012 ESMO 116.pdf | 59.57 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.